Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06206525 · ClinicalTrials.gov registry record · NA
Feasibility Trial Using an Inpatient Insulin Dosing Calculator
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT06206525 is a NA study that has completed, run by University of Washington. The registered enrollment target is 38 participants.
The verdict
NCT06206525, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are: * Whether using this calculator leads to no excessive hypoglycemia? * Whether using this calculator leads to a decrease of hyperglycemia? Participants will receive initial insulin doses by the calculator on hospital admission, and the rest of care will follow standard of care. Participants will be compared with patients in the UW observational cohort who received initial insulin doses by standard of care.
Interventions
- OTHER Initial insulin dosing calculator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-03-22 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06206525
The ClinicalTrials.gov registry entry for NCT06206525 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Initial insulin dosing calculator is the first listed.
NCT06206525 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06206525 about?
NCT06206525 is a clinical study titled "Feasibility Trial Using an Inpatient Insulin Dosing Calculator". The goal of this feasibility trial is to test whether a novel insulin dosing calculator can improve blood glucose management for patients with type 2 diabetes mellitus on hospital admission. The main questions it aims to answer are: * Whether using this calculator leads to no excessive hypoglycemia...
What is the current status of trial NCT06206525?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2024-03-22. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT06206525?
The interventions under investigation include: Initial insulin dosing calculator (OTHER).
Who is sponsoring clinical trial NCT06206525?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.